Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

Cxj Group Co., Ltd
CXJ Group Co., Limited engages in the trading of automobile exhaust cleaners and auto parts in China. It also offers brand name authorization and management, and related training services for Teenage Hero Car brand name. The company was formerly known as Global Entertainment Corp. and changed its name to CXJ Group Co., Limited in 2019. CXJ Group Co., Limited was incorporated in 1998 and is based in Hangzhou, China.
ECXJ
Cyanotech Corp
Cyanotech Corporation, a world leader in microalgae technology for more than 40 years, produces BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. These all-natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. The Company's mission is to fulfill the promise of whole health through Hawaiian microalgae. Cyanotech's BioAstin® offers superior antioxidant activity which supports skin, eye and joint health, as well as recovery from exercise. Cyanotech's Spirulina products offer nutrition that supports cardiovascular health and immunity. All Cyanotech products are produced from microalgae grown at our 96-acre facility in Kona, Hawaii using patented and proprietary technology and are Generally Recognized as Safe ('GRAS') for use in food products. Cyanotech sells its products direct to consumers at retail locations in the United States and online at www.nutrex-hawaii.
CYAN
Cyber Enviro-tech, Inc.
Cyber Enviro-Tech, Inc. (CETI) is an environmental remediation and water treatment company focused on produced-water treatment, hazardous waste removal, and remediation of soil, sludge, and industrial wastewater. CETI is developing proprietary bioremedial materials and data-driven technologies intended to support future pilot programs and commercial applications across oil and gas, mining, agriculture, and municipal markets.
CETI
Cyber Hornet S&p Crypto 10 Etf
No description
CTX
Cyberark Software Ltd.
CyberArk (NASDAQ: CYBR ) is the global leader in identity security, trusted by organizations around the world to secure human and machine identities in the modern enterprise. CyberArk's AI-powered Identity Security Platform applies intelligent privilege controls to every identity with continuous threat prevention, detection and response across the identity lifecycle. With CyberArk, organizations can reduce operational and security risks by enabling zero trust and least privilege with complete visibility, empowering all users and identities, including workforce, IT, developers and machines, to securely access any resource, located anywhere, from everywhere.
CYBR
Cyberloq Technologies, Inc.
CyberloQ Technologies, Inc. (OTCQB: CLOQ) is a cybersecurity technology company dedicated to combating fraud through advanced multi-factor authentication, geofencing, and adaptive risk analysis. Its flagship CyberloQ Secure(TM) platform delivers proactive, integrated protection for customer accounts, digital assets, and transactions. For more information, visit www.cyberloq.com.
CLOQ
Cybin Inc.
Helus Pharma, originally founded as Cybin Inc. in 2019, is a clinical-stage pharmaceutical company committed to helping minds heal by developing proprietary novel serotonergic agonists (NSAs); synthetic molecules designed to activate serotonin pathways believed to promote neuroplasticity. Helus' NSAs are intended to address the significant unmet needs of people living with depression, anxiety, and other mental health conditions. With class-leading clinical data, Helus Pharma aims to advance the mental health treatment landscape through therapies designed to deliver durable improvements. The Company is developing HLP003, a proprietary NSA in Phase 3 clinical development for the adjunctive treatment of major depressive disorder that has received FDA Breakthrough Therapy Designation, and HLP004, a proprietary NSA in Phase 2 development for generalized anxiety disorder. Helus also maintains a robust research portfolio of investigational NSAs.
HELP
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. ("Cyclerion" or the "Company") is a biopharmaceutical company focused on building a new pipeline of therapeutics for neuropsychiatric diseases, with CYC-126, an individualized therapy for TRD, as its foundational product candidate. Given the significant unmet medical need in TRD, the program's stage of clinical development, and the strong commercial opportunity, the Company believes this program is well positioned to serve as the cornerstone of its future growth. Cyclerion became an independent, publicly traded company on April 1, 2019, following a tax-free spin-off from Ironwood Pharmaceuticals, Inc. The Company was originally established to develop novel soluble guanylate cyclase (sGC) stimulators for serious diseases in both the central nervous system and the periphery.
CYCN
Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. More info: www.cycurion.
CYCU
Cyngn Inc.
Cyngn develops and deploys autonomous vehicle technology for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges facing industrial organizations today, such as labor shortages and costly safety incidents. Cyngn's DriveMod technology empowers customers to seamlessly bring self-driving technology to their operations without high upfront costs or infrastructure installations. DriveMod is currently available on Motrec MT-160 Tuggers and BYD Forklifts. The DriveMod Tugger hauls up to 12,000 lbs, travels inside and out, and targets a typical payback period of less than 2 years. The DriveMod Forklift lifts heavy loads that use non-standard pallets and is currently available to select customers.
CYN
Cypherpunk Technologies Inc.
Cypherpunk Technologies Inc. is a privacy technology company implementing a digital asset treasury strategy anchored by Zcash and, through its subsidiary Leap Therapeutics, Inc., is developing novel therapies for patients with cancer. The Company is aiming to build long-term shareholder value by acquiring ZEC, participating in the development of Zcash, and continuing the development of sirexatamab and FL-501 to treat patients with cancer.
CYPH
Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP®) technology. Cytek's novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek's platform includes: its core FSP instruments, the Cytek Aurora, Northern Lights, Cytek Aurora CS and Cytek Aurora Evo systems; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometers and imaging products under the Amnis® and Guava® brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers.
CTKB
Cytodyn Inc.
CytoDyn is a clinical-stage oncology company dedicated to advancing leronlimab, a first-in-class humanized monoclonal antibody that targets the CCR5 receptor, a key regulator of immune function implicated in cancer, infectious diseases, and autoimmune disorders. Guided by a mission to improve patients' quality of life through therapeutic innovation, CytoDyn is committed to integrity, responsibility, and service as it works to bring transformative treatments to patients worldwide.
CYDY
Cytokinetics Inc
Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. Cytokinetics' MYQORZO ( aficamten ) is a cardiac myosin inhibitor approved for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms by the U.S. Food and Drug Administration and the China National Medical Products Administration. The Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending marketing authorization in the European Union for MYQORZO® ( aficamten ) with a decision expected from the European Commission in first quarter in 2026.
CYTK
Cytomed Therapeutics Ltd
Incorporated in 2018, CytoMed was spun off from the Agency for Science, Technology and Research (A*STAR), Singapore's leading research and development agency in the public sector. CytoMed is a clinical stage biopharmaceutical company focused on harnessing its licensed proprietary technologies, namely gamma delta T cell and iPSC-derived gamma delta Natural Killer T cell, to create novel cell-based allogeneic immunotherapies for the treatment of various human cancers. The development of novel technologies has been inspired by the clinical success of existing CAR-T therapies in treating haematological malignancies, as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumours.
GDTC
Cytomx Therapeutics, Inc.
CytomX is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated, masked biologics designed to be localized to the tumor microenvironment. By pioneering a novel pipeline of localized biologics, powered by its PROBODY® therapeutic platform, CytomX's vision is to create safer, more effective therapies for the treatment of cancer. CytomX's robust and differentiated pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates ("ADCs"), T-cell engagers, and immune modulators such as cytokines. CytomX's clinical-stage pipeline includes varsetatug masetecan (formerly CX-2051) and CX-801. Varseta-M is a masked, conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM), armed with a topoisomerase-1 inhibitor payload and was discovered in collaboration with ImmunoGen, now part of AbbVie.
CTMX
Cytosorbents Corp
CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. CytoSorbents' proprietary blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Cartridges filled with these beads can be used with standard blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the body. CytoSorbents' technologies are used in a number of broad applications.
CTSO
Cytta Corp.
Cytta Corp is a pioneering technology company specializing in developing and commercializing cutting-edge safety and security solutions, including CyttaCOMMS and CyttaCARES . Cytta's proprietary innovations redefine real-time intelligence, data security, and mission-critical communications for industries spanning defense, public safety, critical infrastructure, and enterprise operations. Cytta Corp. has now created Cytta Labs to accelerate its technologies by creating Special Purpose Vehicles as spinouts to rapidly develop and monetize technologies. Cytta Labs is the engine behind this spinout model. As a wholly owned subsidiary of Cytta Corp., Cytta Labs identifies, structures, and accelerates breakthrough technologies, preparing them for independent financing and public listing. By channeling innovation through Cytta Labs, we are able to create subsidiaries like IGAN Corp. while ensuring that Cytta Corp. . retains significant equity ownership in each venture.
CYCA
D-market Electronic Services & Trading
Hepsiburada is a leading e-commerce technology platform in Türkiye, operating through a hybrid model that combines first-party direct sales (1P) and a third-party marketplace (3P) with approximately 101 thousand merchants. With its vision of leading the digitalization of commerce, Hepsiburada serves as a reliable, innovative and purpose-driven companion in consumers' daily lives. Hepsiburada's e-commerce platform offers a broad ecosystem of capabilities for merchants and consumers including last-mile delivery, fulfilment services, advertising solutions, cross-border sales, payment services and affordability solutions. Hepsiburada's integrated fintech platform, Hepsipay, provides secure payment solutions, including digital wallets, general-purpose loans, buy now pay later (BNPL) and one-click checkout, enhancing shopping convenience for consumers across online and offline while driving higher sales conversions for merchants.
HEPS
D-wave Quantum Inc.
D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. It is the world's first commercial supplier of quantum computers, and the first and only to offer dual-platform quantum computing products and services, spanning both annealing and gate-model quantum computing technologies. D-Wave's mission is to help customers realize the value of quantum today through enterprise-grade systems available on-premises and via its Leap quantum cloud service, which offers 99.9% availability and uptime. More than 100 organizations across commercial, government and research sectors trust D-Wave to address complex computational challenges using quantum computing. Learn more about realizing the value of quantum computing today and how we're shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.
QBTS
D. Boral Acquisition I Corp.
No description
DBCA
D. Boral Arc Acquisition I Corp.
No description
BCAR
Daedalus Special Acquisition Corp.
No description
DSAC
Daikin Industries Ltd
Daikin Industries is one of the world's largest heating, ventilating and air conditioning, or HVAC, companies. North America, Japan, China, and Europe are Daikin's four biggest markets, accounting for 24.1%, 23.7%, 16.7%, and 14.5% of fiscal 2018 revenue, respectively. Air conditioning accounted for around 90% of revenue and operating profit, while chemicals and others made up the balance.
DKILF
Daily Journal Corp
Daily Journal Corporation, based in Los Angeles, publishes news for California and Arizona, produces specialized publications, and handles public notice advertising. Its subsidiary, Journal Technologies, Inc., provides case management software to courts, justice agencies, and government organizations across about 37 states and internationally, supporting electronic case management and related online services like e-filing and fee payments.
DJCO
Daimler Ag
Mercedes-Benz Group AG operates as an automotive company in Germany and internationally. It operates through Mercedes-Benz Cars, Mercedes-Benz Vans, and Mercedes-Benz Mobility segments. The company develops, manufactures, and sells cars and vans under the Mercedes-Benz, Mercedes-AMG, Mercedes-Maybach, G-Class brands, as well as related spare parts and accessories. It also provides financing, leasing, car subscription and rental, fleet management, insurance brokerage, and mobility services, as well as digital services for charging and payment. The company was formerly known as Daimler AG and changed its name to Mercedes-Benz Group AG in February 2022. Mercedes-Benz Group AG was founded in 1886 and is headquartered in Stuttgart, Germany.
MBGAF
Daiwa Securities Group Inc.
Together with industry leader Nomura, Daiwa Securities is one of two large independent securities firms in Japan. Like Nomura, it competes with brokerage units of the megabanks and smaller independent firms in Japan, but unlike Nomura it does not have aspiration to compete globally with the major U.S. and European investment banks and focuses on Japan-related business only. Daiwa moved its global wholesale business to a joint venture with Sumitomo Bank in 1999, but the venture met only mixed success and Daiwa ultimately bought out Sumitomo Mitsui Financial Group's 40% interest in the venture in 2009 after SMFG opportunistically purchased Nikko Securities (now SMBC Nikko, a rival of Daiwa) from Citigroup.
DSEEY
Dakota Gold Corp.
Dakota Gold is expanding the legacy of the 145-year-old Homestake Gold Mining District by advancing the Richmond Hill Oxide Heap Leach Gold Project to commercial production as soon as 2029, and outlining a tertiary maiden resource as well as a high-grade underground gold resource at the Maitland Gold Project, both located on private land in South Dakota.
DC
Daktronics Inc
Daktronics has strong leadership positions in, and is the world's largest supplier of, large-screen video displays, electronic scoreboards, LED text and graphics displays, and related control systems. The Company excels in the control of display systems, including those that require integration of multiple complex displays showing real-time information, graphics, animation, and video. Daktronics designs, manufactures, markets and services display systems for customers around the world in four domestic business units: Live Events, Commercial, High School Park and Recreation, and Transportation, and one International business unit.
DAKT
Dalrada Technology Group, Inc.
No description
DHTI